Carregant...
Comparison of in vivo Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated Irradiation
Development of strategies to eradicate radioresistant hypoxic cells would be of great benefit for clinical radiotherapy. In the present study, the in vivo effects of a promising hypoxic cytotoxin, tirapazamine (3‐amino‐1,2,4‐benzotriazine 1,4‐di‐N‐oxide), were examined in comparison with those of KU...
Guardat en:
Publicat a: | Jpn J Cancer Res |
---|---|
Autors principals: | , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Blackwell Publishing Ltd
1996
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920986/ https://ncbi.nlm.nih.gov/pubmed/8609056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00206.x |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|